Table 1 Demographic and clinical background profiles of study participants.
|  | ASD (n = 13) | SCZ (n = 15) | Healthy (n = 18) | p |
|---|---|---|---|---|
Age, years | 30 [23.3–38.5] | 36 [29–47] | 34.5 [28–38.5] | 0.18a |
Sex(M/F) | 12/1 | 12/3 | 13/5 | 0.38b |
JART IQ | 106.0 [99.5–115.9] | 100.0 [91.3–109.6] | 102.9 [94.9–107.9] | 0.32a |
AQ | ||||
Social skills | 8 [5–9] | — | — | — |
Attention switching | 8 [5–9] | — | — | — |
Attention to detail | 5 [3–7] | — | — | — |
Communication | 6 [4–8] | — | — | — |
Imagination | 5 [4–6] | — | — |  |
Total | 31 [25–34.5] | — | — | — |
PANSS | ||||
Positive factor | — | 9 [7–10] | — | — |
Negative factor | — | 14 [12–21] | — | — |
General psychopathology | — | 21 [19–24] | — | — |
Total | — | 45 [41–53] | — | — |
Chlorpromazine eq.(mg) | 0 [0–75] | 800 [489.4–1300] | — | <0.01c |
Imipramine eq.(mg) | 38 [6.3–12.5] | 0 [0–0] | — | <0.01c |
Duration of illness(years) | — | 11 [8–23] |  | — |
